BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23962115)

  • 1. Tumor-induced osteomalacia resulting from primary cutaneous phosphaturic mesenchymal tumor: a case and review of the medical literature.
    Gardner KH; Shon W; Folpe AL; Wieland CN; Tebben PJ; Baum CL
    J Cutan Pathol; 2013 Sep; 40(9):780-4; quiz 779. PubMed ID: 23962115
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of phosphaturic mesenchymal tumour (mixed connective tissue variant) that developed in the subcutaneous tissue of a patient with oncogenic osteomalacia and produced fibroblast growth factor 23.
    Oka M; Kamo T; Sasaki E; Kaji H; Nishizawa H; Imanishi Y; Nishigori C
    Br J Dermatol; 2007 Jul; 157(1):198-200. PubMed ID: 17489977
    [No Abstract]   [Full Text] [Related]  

  • 3. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple phosphaturic mesenchymal tumors associated with oncogenic osteomalacia: case report and review of the literature.
    Peterson NR; Summerlin DJ; Cordes SR
    Ear Nose Throat J; 2010 Jun; 89(6):E11-5. PubMed ID: 20556724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphaturic mesenchymal tumors. Survey of 8 cases from a single Mexican medical institution.
    Angeles-Angeles A; Reza-Albarrán A; Chable-Montero F; Cordova-Ramón JC; Albores-Saavedra J; Martinez-Benitez B
    Ann Diagn Pathol; 2015 Dec; 19(6):375-80. PubMed ID: 26386520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type.
    Graham RP; Hodge JC; Folpe AL; Oliveira AM; Meyer KJ; Jenkins RB; Sim FH; Sukov WR
    Hum Pathol; 2012 Aug; 43(8):1334-8. PubMed ID: 22503486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic quiz case. A 36-year-old woman with muscle pain and weakness. Phosphaturic mesenchymal tumor (mixed connective tissue variant)/oncogenic osteomalacia.
    Reis-Filho JS; Paiva ME; Lopes JM
    Arch Pathol Lab Med; 2002 Oct; 126(10):1245-6. PubMed ID: 12385334
    [No Abstract]   [Full Text] [Related]  

  • 8. Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue.
    Uramoto N; Furukawa M; Yoshizaki T
    Auris Nasus Larynx; 2009 Feb; 36(1):104-5. PubMed ID: 18329207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteomalacia cured by resection of cutaneous neurinoma].
    Caille A; Crouzet J; Mimoune H; Duterque M; Perrin P; Verola O
    Ann Dermatol Venereol; 1996; 123(12):829-31. PubMed ID: 9636774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma.
    Stone E; Bernier V; Rabinovich S; From GL
    Clin Invest Med; 1984; 7(3):179-85. PubMed ID: 6518684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypophosphatemic osteomalacia secondary to a vascular fibrous histiocytoma].
    Insua Vilariño SA; Díaz Garel J; Caamaño Freire M; Mera Varela A; Buelta Carrillo L; Pérez Becerra E; Varela Durán J
    Rev Clin Esp; 1993 Oct; 193(6):293-5. PubMed ID: 8259452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phosphaturic mesenchymal tumor of the floor of the mouth with oncogenic osteomalacia: report of a case.
    Yun KI; Kim DH; Pyo SW
    J Oral Maxillofac Surg; 2009 Feb; 67(2):402-5. PubMed ID: 19138617
    [No Abstract]   [Full Text] [Related]  

  • 14. Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.
    Puthenveetil PJ; Hattab EM; Peacock M; Horn EM
    J Clin Neurosci; 2013 Aug; 20(8):1057-61. PubMed ID: 23618679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oncogenic osteomalacia: its pathogenesis, clinical picture and treatment].
    Ermolenko VM; Melikaian AM; Shotemor ShSh; Potapova AV
    Ter Arkh; 1995; 67(5):58-61. PubMed ID: 7638783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic osteomalacia from pterygopalatine fossa mass.
    Savage CR; Zimmer LA
    J Laryngol Otol; 2009 Sep; 123(9):1052-4. PubMed ID: 19250593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphaturic mesenchymal tumor diagnosed by fine-needle aspiration and core biopsy: a case report and review of literature.
    Policarpio-Nicolas ML; Abbott TE; Dalkin AC; Bennett-Wick J; Frierson HF
    Diagn Cytopathol; 2008 Feb; 36(2):115-9. PubMed ID: 18181193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the femur: A case report.
    Tang D; Wang XM; Zhang YS; Mi XX
    World J Clin Cases; 2019 Aug; 7(15):2081-2086. PubMed ID: 31423441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteomalacia and giant cell tumor: a rare case].
    Sehli H; Daoud L; Ben Mbarek R; Ghorbel R; Ben Abdelghani K; Charfi H; Cheour I; Tarhouni L; Sellami S
    Tunis Med; 2008 Sep; 86(9):836-8. PubMed ID: 19472787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).
    Houang M; Clarkson A; Sioson L; Elston MS; Clifton-Bligh RJ; Dray M; Ranchere-Vince D; Decouvelaere AV; de la Fouchardiere A; Gill AJ
    Hum Pathol; 2013 Dec; 44(12):2711-8. PubMed ID: 24060005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.